In the early 90s, when Gumboro disease was causing mortality ranging from 10% to 90% in almost every farm in the country ... where no other vaccine, Indian or International could provide effective protection against Gumboro... the Intermediate strain, followed by Invasive Intermediate strain and then a broiler specific Gumboro vaccine from INDOVAX have brought this highly dreaded disease under control. It is, therefore, not surprising that INDOVAX enjoys over 40 % market share in Gumboro segment.

INDOVAX’s Hydropericardium syndrome vaccine and Fowl cholera vaccine have a similar success story.

The company has structurally aligned itself to total quality management and has set standards that most biological companies in India find difficult to match.

INDOVAX continues to expand and has established itself as India’s leading poultry biological company. It’s products are, in most cases, the only choice for poultry farmers, veterinarians and consultants.

Continued growth - a reflection of

Product Performance & Customer Confidence